OPEN Access Consulting believes that a compelling value strategy, supported by a robust and appropriate evidence base, should be at the heart of all activities to optimise patient access to life-changing healthcare interventions. We work in partnership with the life-sciences industry in the development and delivery of robust product value strategies throughout the product life cycle at a UK, EU and Global level. Our high-calibre, experienced team ensures that all stakeholders involved in the decision-making pathway to fund, prescribe and deliver products and services are considered, and that a robust programme of activities is created and implemented to optimise uptake of the product. At OPEN Access Consulting, we recognise that demonstrating value is getting tougher and that there is a requirement from payers, physicians and patients for stronger, more compelling supporting evidence. Our unique market access offering works closely in partnership with our OPEN Health sister companies to ensure the entire value strategy and market access programme is underpinned with the right data, at the right time, to drive a change in practice.